Literature DB >> 16140547

Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.

Simone M Smits1, Daniel S Mathon, J Peter H Burbach, Geert M J Ramakers, Marten P Smidt.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of midbrain dopaminergic (mDA) neurons in the substantia nigra compacta (SNc). In order to provide insights into adaptive mechanisms of the mDA system in pathology, specific molecular and cellular parameters of the mDA system were studied in Pitx3-deficient Aphakia (ak) mice, which suffer from severe developmental failure of SNc mDA neurons. Here, we demonstrate differential changes in striatal gene expression, reflecting the specific neuronal loss in these mice. In addition, the neuronal activity of remaining mDA neurons in the ventral tegmental area (VTA) was significantly increased in ak mice. In conclusion, ak mice display specific molecular and cellular alterations in the mDA system that provide new insights in compensatory mechanisms present in mDA-associated disorders such as PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140547     DOI: 10.1016/j.mcn.2005.07.018

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  12 in total

1.  Dopamine-dependent motor learning: insight into levodopa's long-duration response.

Authors:  Jeff A Beeler; Zhen Fang Huang Cao; Mazen A Kheirbek; Yunmin Ding; Jessica Koranda; Mari Murakami; Un Jung Kang; Xiaoxi Zhuang
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

2.  Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice.

Authors:  Yunmin Ding; Lisa Won; Jonathan P Britt; Sean Austin O Lim; Daniel S McGehee; Un Jung Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 3.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

Review 4.  Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons.

Authors:  F M J Jacobs; S M Smits; K J M Hornman; J P H Burbach; M P Smidt
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

5.  Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.

Authors:  Yunmin Ding; Jacqueline Restrepo; Lisa Won; Dong-Youn Hwang; Kwang-Soo Kim; Un Jung Kang
Journal:  Neurobiol Dis       Date:  2007-04-10       Impact factor: 5.996

Review 6.  Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches.

Authors:  Jean-Francois Poulin; Zachary Gaertner; Oscar Andrés Moreno-Ramos; Rajeshwar Awatramani
Journal:  Trends Neurosci       Date:  2020-02-11       Impact factor: 13.837

7.  Loss of cocaine locomotor response in Pitx3-deficient mice lacking a nigrostriatal pathway.

Authors:  Jeff A Beeler; Zhen Fang Huang Cao; Mazen A Kheirbek; Xiaoxi Zhuang
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

8.  Motor deficits and altered striatal gene expression in aphakia (ak) mice.

Authors:  Bhupinder Singh; Jean H Wilson; Hema H Vasavada; Zhenchao Guo; Heather G Allore; Caroline J Zeiss
Journal:  Brain Res       Date:  2007-09-16       Impact factor: 3.252

9.  Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis.

Authors:  Ghiabe-Henri Guibinga; Stephen Hsu; Theodore Friedmann
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

10.  Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system.

Authors:  Edgar R Kramer; Liviu Aron; Geert M J Ramakers; Sabine Seitz; Xiaoxi Zhuang; Klaus Beyer; Marten P Smidt; Rüdiger Klein
Journal:  PLoS Biol       Date:  2007-03       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.